Passage of bovine serum albumin from the mother to rabbit blastocysts

Development ◽  
1973 ◽  
Vol 30 (2) ◽  
pp. 471-482
Author(s):  
Abraham C. Kulangara ◽  
Floy L. Crutchfield

Passage of bovine serum albumin (BSA) into unimplanted rabbit blastocysts was studied using intravenous or intrauterine injection of the mother and in vitro cultivation of 5-day blastocysts. BSA concentration in blastocyst fluid was measured using a quantitative radial immunodiffusion method and confirmed by double diffusion in agar. Intravenous injection of up to 200 mg/kg body weight produced a mean concentration of 106 μg/ml in uterine fluid and the blastocyst fluid was mostly negative. In vitro cultivation with 1–20 mg BSA/ml resulted in appreciable passage which was confirmed by intra-uterine injection. BSA appeared in blastocyst fluid after 2–3 h of exposure. After 24 h, 0·25–2·0 μg BSA was accumulated. The highest concentration observed in blastocyst fluid was 338 μg/ml and this was about 1·7% of the surrounding concentration. Combined with previous results on passage from plasma into uterine fluid, it could be calculated that in 24 h the blastocyst fluid acquired about 0·08% of the maternal serum concentration of BSA. The accumulation of BSA by the blastocyst is about half that of rabbit albumin in the same period (5–6 days p.c.), which suggests that the unimplanted blastocyst is capable of discriminating between native and foreign serum albumin.

Development ◽  
1973 ◽  
Vol 30 (2) ◽  
pp. 459-469
Author(s):  
Floy L. Crutchfield ◽  
Abraham C. Kulangara

Dutch belted rabbits were given single intravenous injections of 100 or 200 mg/kg doses of bovine serum albumin (BSA). BSA in serum and uterine fluid at various times after injection was estimated by a quantitative radial immunodiffusion test, which could measure a minimum of 40 ng. The presence of BSA in uterine fluid was confirmed by immunoelectrophoresis and double diffusion in agar. BSA passes readily into uterine fluid of non-pregnant rabbits, reaching a peak at 12 h after injection, when its concentration is 7–15% of that in serum. About 72 h seems to be required for equilibration of BSA between serum and uterine fluid, at which time the concentration in the former is about 5 times that in the latter. The kinetics of the process is discussed. Compared to the above, passage of BSA into uterine fluid of pregnant rabbits (5–7 days post coitum) is restricted in the following ways. Significant amounts of BSA appear in the fluid only after a maternal dose of 200 mg/kg. BSA in uterine fluid reaches a peak at 24 h after injection, when it is only 4·5% of the serum level. The permeability rate seems to decrease with early gestation. Approximate rates of entry of BSA into uterine lumen of non-pregnant and pregnant rabbits are 0·4 and 0·25 μg/h. BSA seems to be treated like rabbit albumin in its passage across the uterine epithelium. There is no evidence of selection between these proteins.


1969 ◽  
Vol 26 (5) ◽  
pp. 1392-1397 ◽  
Author(s):  
James E. Stewart ◽  
Diane M. Foley

The levels of fluorescent material in the hemolymph of lobsters injected with serum proteins from lobster hemolymph labelled with fluorescein remained relatively constant over a 6-day test period; the levels in lobsters injected with bovine serum albumin labelled with fluorescein declined rapidly. A precipitin-like reaction was observed when lobster hemolymph serum was titrated with bovine serum albumin in vitro.


2006 ◽  
Vol 16 (9) ◽  
pp. 2450-2453 ◽  
Author(s):  
Xiong-Jie Jiang ◽  
Jian-Dong Huang ◽  
Yu-Jiao Zhu ◽  
Fen-Xiang Tang ◽  
Dennis K.P. Ng ◽  
...  

2021 ◽  
Author(s):  
Alessandra Capezzone de Joannon ◽  
Angela Testa ◽  
Natalie Falsetto ◽  
Michela Procaccini ◽  
Lorella Ragni

Aim: Ethanol is highly effective at inactivating enveloped viruses, including SARS-CoV-2. The aim of this study is to evaluate the virucidal activity of Amuchina Gel Xgerm (74% ethanol) against SARS-CoV-2, according to the European Standard EN14476:2013+A2:2019. Materials & methods: Virucidal activity of the study product was evaluated against SARS-CoV-2 strain USAWA1/2020 in suspension, in the presence of 0.3 g/l of bovine serum albumin. Results: The log10 reduction of SARS-CoV-2 in the presence of bovine serum albumin was ≥4.11 ± 0.12 after 30 s of exposure to the study product (80% dilution). Cytotoxicity was observed in the 100 dilution, affecting the detection limit by 1 log10. Conclusion: Virucidal activity against SARS-CoV-2 supports the effectiveness of this alcohol-based formulation as a prevention measure for COVID-19 illness.


2008 ◽  
Vol 2 (1) ◽  
Author(s):  
Md Ashraful Alam ◽  
Md Abdul Awal ◽  
Mahbub Mostofa ◽  
Md Kamrul Islam ◽  
Nusrat Subhan

1989 ◽  
Vol 6 (3) ◽  
pp. 164-167 ◽  
Author(s):  
Claudio A. Benadiva ◽  
Barbara Kuczynski-Brown ◽  
Tobi G. maguire ◽  
Luigi Mastroianni ◽  
George L. Flickinger

2010 ◽  
Vol 39 (4) ◽  
pp. 482-494 ◽  
Author(s):  
Xiaolei Shi ◽  
Xuwen Li ◽  
Yantao Sun ◽  
Wei Wei ◽  
Ruijie Yang ◽  
...  

1983 ◽  
Vol 212 (2) ◽  
pp. 249-257 ◽  
Author(s):  
M J Imber ◽  
S V Pizzo

These studies explore the role of carbohydrate recognition systems and the direct involvement of terminal alpha 1-3-linked fucose in the clearance of lactoferrin from the murine circulation and in the specific binding of lactoferrin to receptors on murine peritoneal macrophages. As previously reported, radiolabelled lactoferrin cleared very rapidly (t1/2 less than 1 min) after intravenous injection into mice. However, competing levels of ligands specific for the hepatic galactose receptor (asialo-orosomucoid), the hepatic fucose receptor (fucosyl-bovine serum albumin), and the mononuclear-phagocyte system pathway recognizing mannose, N-acetylglucosamine and fucose (mannosyl-, N-acetylglucosaminyl- and fucosyl-bovine serum albumin) did not block radiolabelled lactoferrin clearance in vivo or binding to mouse peritoneal macrophage monolayers in vitro. Almond emulsin alpha 1-3-fucosidase was used to prepare defucosylated lactoferrin in which 88% of the alpha 1-3-linked fucose was hydrolysed. No difference in clearance or receptor binding was observed between radiolabelled native and defucosylated lactoferrin. Fucoidin, a fucose-rich algal polysaccharide, completely inhibits the clearance in vivo and macrophage binding in vitro of lactoferrin. This effect, however, is probably not the result of competition for binding to the fucose receptor, since gel-filtration studies demonstrated formation of a stable complex between lactoferrin and fucoidin. The present results indicate that the lactoferrin-clearance pathway is distinct from several pathways mediating glycoprotein clearance through recognition of terminal galactose, fucose, N-acetylglucosamine or mannose. Furthermore, alpha 1-3-linked fucose on lactoferrin is not essential for lactoferrin clearance in vivo or specific binding to macrophage receptors in vitro.


2011 ◽  
Vol 30 (12) ◽  
pp. 2697-2700 ◽  
Author(s):  
Yingxin Wu ◽  
Yan Qian ◽  
Hao Cui ◽  
Xiaomin Lai ◽  
Xianchuan Xie ◽  
...  

Nanomedicine ◽  
2021 ◽  
Author(s):  
Andre Gonçalves Prospero ◽  
Lais Pereira Buranello ◽  
Carlos AH Fernandes ◽  
Lucilene Delazari dos Santos ◽  
Guilherme Soares ◽  
...  

Background: We evaluated the impacts of corona protein (CP) formation on the alternating current biosusceptometry (ACB) signal intensity and in vivo circulation times of three differently coated magnetic nanoparticles (MNP): bare, citrate-coated and bovine serum albumin-coated MNPs. Methods: We employed the ACB system, gel electrophoresis and mass spectrometry analysis. Results: Higher CP formation led to a greater reduction in the in vitro ACB signal intensity and circulation time. We found fewer proteins forming the CP for the bovine serum albumin-coated MNPs, which presented the highest circulation time in vivo among the MNPs studied. Conclusion: These data showed better biocompatibility, stability and magnetic signal uniformity in biological media for bovine serum albumin-coated MNPs than for citrate-coated MNPs and bare MNPs.


Sign in / Sign up

Export Citation Format

Share Document